quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:12:56·51d
INSIDERFiling
Clean Energy Fuels Corp. logo

SVP, STRATEGIC DEVELOPMENT Corbus Barclay covered exercise/tax liability with 31,198 shares and was granted 200,000 shares, increasing direct ownership by 16% to 1,230,050 units (SEC Form 4)

CLNE· Clean Energy Fuels Corp.
Utilities
Original source

Companies

  • CLNE
    Clean Energy Fuels Corp.
    Utilities

Recent analyst ratings

  • Aug 8UpdateJefferies-
  • Oct 3UpdateRaymond James$6.00
  • Sep 5UpdateNorthland Capital$7.50
  • Jul 13UpdateStifel$6.00
  • Apr 5UpdateRaymond James$6.00
  • Feb 28UpdatePiper Sandler$8.00

Related

  • SEC1d
    Clean Energy Fuels Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR1d
    Clay Corbus named President and CEO of Clean Energy Fuels Corp.
  • PR10d
    Clean Energy to Report First Quarter 2026 Financial Results on May 7; Conference Call to Follow at 1:30 p.m. Pacific Time
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Clean Energy Fuels Corp.
  • INSIDER49d
    SVP, STRATEGIC DEVELOPMENT Corbus Barclay covered exercise/tax liability with 60,561 shares, decreasing direct ownership by 5% to 1,169,489 units (SEC Form 4)
  • INSIDER49d
    CHIEF FINANCIAL OFFICER Vreeland Robert M. covered exercise/tax liability with 30,982 shares, decreasing direct ownership by 4% to 832,274 units (SEC Form 4)
  • INSIDER49d
    CEO AND PRESIDENT Littlefair Andrew J covered exercise/tax liability with 41,976 shares, decreasing direct ownership by 2% to 1,676,738 units (SEC Form 4)
  • PR51d
    RNG Continues to Lead as the Easy-to-Switch Clean Fuel for Multi-Sector Fleets Signing New Agreements With Clean Energy
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022